Patents Assigned to Neurodyn, Inc.
  • Nurotoxic sterol glycosides
    Patent number: 9573972
    Abstract: The invention relates to compositions for use in animal models of neurodegenerative disease and methods therefor. More particularly, the invention relates to the use of neurotoxic sterol glycosides or neurotoxic glycolipids, or combinations thereof, in animal models of neurodegenerative disease. Neurotoxicity-modulating chromenols can also be used in these animal models in combination with the neurotoxic sterol glycosides or neurotoxic glycolipids, or combinations thereof.
    Type: Grant
    Filed: October 30, 2009
    Date of Patent: February 21, 2017
    Assignee: NEURODYN, INC.
    Inventors: Christopher Ariel Shaw, Denis George Kay
  • Sterol glucoside toxins
    Patent number: 8497123
    Abstract: The invention relates to the identification of sterol glucoside toxins, and provides methods for detecting and detoxifying the compounds, as well as therapeutic methods for treating subjects exposed to such toxins. In alternative embodiments, the toxins may for example include beta-sitostrol-beta-D-glucoside (5-cholesten-24b-ethyl-3b-ol-D-glucoside) or cholesterol glucoside (5-cholesten-3b-ol-3b-D-glucoside).
    Type: Grant
    Filed: March 30, 2012
    Date of Patent: July 30, 2013
    Assignee: Neurodyn, Inc.
    Inventors: Christohper A. Shaw, Raymond J. Andersen, David E. Williams, Jaswinder Bains
  • STEROL GLUCOSIDE TOXINS
    Publication number: 20120244632
    Abstract: The invention relates to the identification of sterol glucoside toxins, and provides methods for detecting and detoxifying the compounds, as well as therapeutic methods for treating subjects exposed to such toxins. In alternative embodiments, the toxins may for example include beta-sitostrol-beta-D-glucoside (5-cholesten-24b-ethyl-3b-ol-D-glucoside) or cholesterol glucoside (5-cholesten-3b-ol-3b-D-glucoside).
    Type: Application
    Filed: March 30, 2012
    Publication date: September 27, 2012
    Applicant: NEURODYN, INC.
    Inventors: Christopher Ariel SHAW, Raymond J. ANDERSEN, David E. WILLIAMS, Jaswinder BAINS
  • Sterol glucoside toxins
    Patent number: 8148336
    Abstract: The invention relates to the identification of sterol glucoside toxins, and provides methods for detecting and detoxifying the compounds, as well as therapeutic methods for treating subjects exposed to such toxins. In alternative embodiments, the toxins may for example include beta-sitosterol-beta-D-glucoside (5-cholesten-24b-ethyl-3b-ol-D-glucoside) or cholesterol glucoside (5-cholesten-3b-ol-3b-D-glucoside).
    Type: Grant
    Filed: June 29, 2006
    Date of Patent: April 3, 2012
    Assignee: Neurodyn, Inc.
    Inventors: Christopher Ariel Shaw, Raymond J Andersen, David E Williams, Jaswinder Bains
  • NEUROTOXIC STEROL GLYCOSIDES
    Publication number: 20110280805
    Abstract: The invention relates to compositions for use in animal models of neurodegenerative disease and methods therefor. More particularly, the invention relates to the use of neurotoxic sterol glycosides or neurotoxic glycolipids, or combinations thereof, in animal models of neurodegenerative disease. Neurotoxicity-modulating chromenols can also be used in these animal models in combination with the neurotoxic sterol glycosides or neurotoxic glycolipids, or combinations thereof.
    Type: Application
    Filed: October 30, 2009
    Publication date: November 17, 2011
    Applicant: NEURODYN, INC.
    Inventors: Christopher Ariel Shaw, Denis George Kay